Leukemia News

The addition of quizartinib to chemotherapy extended OS for certain adults with newly diagnosed acute myeloid leukemia, according to topline data released by the agent’s manufacturer.

In this video, Lori Muffly, MD, MS, discussed an abstract on the impact of genetic ancestry on the biology and disease outcomes of childhood acute lymphoblastic leukemia that was presented at the Society of Hematologic Oncology Annual Meeting.

In this video, Lori Muffly, MD, MS, discussed a debate session that focused on the sequencing and importance of CD19-targeting therapies from the Society of Hematologic Oncology Annual Meeting.

In this video, Lori Muffly, MD, MS, spoke with Healio about her presentation on the use of measurable residual disease in treating acute lymphoblastic leukemia from the Society of Hematologic Oncology Annual Meeting.

In this video, Lori Muffly, MD, MS, discussed a presentation from the Society of Hematologic Oncology Annual Meeting about the how the use of hyper-CVAD for acute lymphoblastic leukemia has evolved over time.

COVID-19 remains a significant global burden, with 5 million worldwide deaths recorded as of October, according to a speaker at Chemotherapy Foundation Symposium.

Management of cancer therapies in the era of COVID-19 infection and vaccination requires careful consideration of both disease and patient characteristics, according to members of a crossfire panel at Chemotherapy Foundation Symposium.

Significant progress has been made in treatment and improving survival outcomes across all subtypes of acute lymphoblastic leukemia, according to a speaker at Chemotherapy Foundation Symposium.

Chimeric antigen receptor T-cell therapy appeared associated with various cardiovascular and pulmonary adverse events, according to results of a retrospective pharmacovigilance study.

The FDA granted orphan drug designation to SEL24/MEN1703 for the treatment of acute myeloid leukemia.